Inactive Instrument

PROTEK

PRTK

RU000A0JQU47

Protek Provides Revenue Guidance for the Year 2013

October 29, 2013 at 06:34 pm IST

Protek plans to increase its revenues in 2013 by nearly 15% on the year to RUB 144 billion.

Latest news about PROTEK

Public Joint-Stock Company Protek Reports Earnings Results for the Full Year Ended December 31, 2019	30/20/30	CI
Protek Group Reports Consolidated Earnings Results for the First Half of 2018	28/18/28	CI
JSC Rafarma announced that it has received funding from Public Joint-Stock Company PROTEK	04/17/04	CI
Protek OOO acquired an additional 0.19% stake in Public Joint-Stock Company PROTEK.	27/17/27	CI
Protek LLC acquired an additional 0.0522% stake in Public Joint-Stock Company PROTEK.	23/17/23	CI
PROTEK Group Announces Unaudited Consolidated Revenue Results for Third Quarter and Nine Months Ended September 30, 2017	26/17/26	CI
The Protek Reports Consolidated Earnings Results for the First Half of Fiscal Year 2017	25/17/25	CI
PROTEK Group Reports Audited Consolidated Earnings Results for the Year 2016	20/17/20	CI
Open Joint Stock Company Protek completed the acquisition of Joint Stock Company Rafarma from Rafarma Pharmaceuticals, Inc..	18/17/18	CI
PROTEK Group Reports Preliminary Consolidated Unaudited Revenue Results for Fourth Quarter and Full Year 2016	09/17/09	CI
Open Joint Stock Company Protek sold 51% stake in Firma Koman Zao.	23/16/23	CI
Ortes ZAO acquired LLC Protek Finance from Public Joint-Stock Company PROTEK.	16/16/16	CI
Protek Reports Unaudited Revenue Results for the Third Quarter and Nine Months of 2016	27/16/27	CI
Protek Group Announces Earnings Results for the First Half of 2016	25/16/25	CI
PROTEK OAO Approves Dividend	04/16/04	CI
PROTEK Group Reports Consolidated Earnings Results for Fiscal 2015	11/16/11	CI
Protek Announces Earnings Results for the First Quarter of 2016	21/16/21	CI
Protek Announces Earnings Results for 2015	21/16/21	CI
Protek Reports Consolidated Sales Results for the Fourth Quarter and Full Year of 2015	11/16/11	CI
Protek Group Reports Preliminary Consolidated Revenue Results for the Third Quarter and Nine Months Ended September 30, 2015	04/15/04	CI
Protek Group Reports Unaudited Consolidated Revenue Results for the Third Quarter and Nine Months Ended September 30, 2015	29/15/29	CI
ZAO CV Protek acquired an additional 0.21% stake in Open joint stock company Protek.	04/15/04	CI
ZAO CV Protek acquired an additional 0.14% stake in Open joint stock company Protek.	02/15/02	CI
Protek Group Reports Earnings Results for the First Half of 2015	27/15/27	CI
SV PROTEK acquired 0.57% stake in Open joint stock company Protek.	11/15/11	CI

Protek PAO is a Russia-based vertically integrated pharmaceutical holding company. Together with its subsidiaries, the Company forms Protek Group, which is engaged in various segments of the pharmaceutical industry. The Company focuses on such business segments as: Distribution, Retail and Production. The Company has three plants involved in the pharmaceuticals, beauty and health products manufacture: FarmFirma Soteks ZAO, Protek-SVM OOO and Proteinovyi Kontur OOO. The Company operates through numerous subsidiaries and affiliated companies, located domestically and in Ukraine, the Virgin Islands and Cyprus.

Sector

Drug Retailers

More about the company

Sector Retail - Drugs with Grocery

	1st Jan change	Capi.
SUNDRUG CO.,LTD.	-11.83%	2.97B
TSURUHA HOLDINGS INC.	-28.03%	2.88B
SUGI HOLDINGS CO.,LTD.	+12.79%	2.81B
LBX PHARMACY CHAIN	+12.41%	2.71B
KUSURI NO AOKI HOLDINGS CO., LTD.	-0.84%	1.91B
CREATE SD HOLDINGS CO., LTD.	+9.79%	1.37B
GREAT TREE PHARMACY CO., LTD.	-22.17%	941M
SHUYU CIVILIAN PHARMACY CORP., LTD.	-36.96%	716M
FARMACIAS BENAVIDES, S.A.B. DE C.V.	-0.53%	453M

Retail - Drugs with Grocery